tiprankstipranks
Advertisement
Advertisement
BriaCell Restructures Soluble CD80 Program via BriaPro Deal
PremiumCompany AnnouncementsBriaCell Restructures Soluble CD80 Program via BriaPro Deal
1M ago
BriaPro to Acquire BriaCell’s Soluble CD80 License in Strategic Cancer Immunotherapy Deal
Premium
Company Announcements
BriaPro to Acquire BriaCell’s Soluble CD80 License in Strategic Cancer Immunotherapy Deal
1M ago
BriaPro to purchase BriaCell’s license to develop, commercialize sCD80
Premium
The Fly
BriaPro to purchase BriaCell’s license to develop, commercialize sCD80
1M ago
BriaCell Reports Prolonged Survival in Phase 2 Metastatic Breast Cancer Trial
PremiumCompany AnnouncementsBriaCell Reports Prolonged Survival in Phase 2 Metastatic Breast Cancer Trial
2M ago
BriaCell extends 18-47 month survival in Phase 2 metastatic breast cancer
Premium
The Fly
BriaCell extends 18-47 month survival in Phase 2 metastatic breast cancer
2M ago
BriaCell Therapeutics Completes $30 Million Public Offering
Premium
Company Announcements
BriaCell Therapeutics Completes $30 Million Public Offering
3M ago
BriaCell reports sustained complete resolution of lung metastasis in Bria-OTS
PremiumThe FlyBriaCell reports sustained complete resolution of lung metastasis in Bria-OTS
3M ago
BriaCell Subsidiary BriaPro Files Interim Financial Results
Premium
Company Announcements
BriaCell Subsidiary BriaPro Files Interim Financial Results
3M ago
BriaCell’s Phase 3 Breast Cancer Trial Named a 2026 ‘Clinical Trial to Watch’ by Nature Medicine
Premium
Company Announcements
BriaCell’s Phase 3 Breast Cancer Trial Named a 2026 ‘Clinical Trial to Watch’ by Nature Medicine
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100